ProKidney Statistics
Total Valuation
ProKidney has a market cap or net worth of $216.81 million. The enterprise value is $1.24 billion.
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ProKidney has 126.05 million shares outstanding. The number of shares has increased by 0.96% in one year.
Shares Outstanding | 126.05M |
Shares Change (YoY) | +0.96% |
Shares Change (QoQ) | +24.54% |
Owned by Insiders (%) | 21.28% |
Owned by Institutions (%) | 33.78% |
Float | 68.47M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.87, with a Debt / Equity ratio of 0.01.
Current Ratio | 21.87 |
Quick Ratio | 21.09 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -15,395.90 |
Financial Efficiency
Return on equity (ROE) is -29.59% and return on invested capital (ROIC) is -20.50%.
Return on Equity (ROE) | -29.59% |
Return on Assets (ROA) | -19.57% |
Return on Capital (ROIC) | -20.50% |
Revenue Per Employee | n/a |
Profits Per Employee | -$237,319 |
Employee Count | 163 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ProKidney has paid $3.75 million in taxes.
Income Tax | 3.75M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.29% in the last 52 weeks. The beta is 1.28, so ProKidney's price volatility has been higher than the market average.
Beta (5Y) | 1.28 |
52-Week Price Change | +14.29% |
50-Day Moving Average | 2.07 |
200-Day Moving Average | 2.13 |
Relative Strength Index (RSI) | 42.32 |
Average Volume (20 Days) | 428,384 |
Short Selling Information
The latest short interest is 10.74 million, so 8.52% of the outstanding shares have been sold short.
Short Interest | 10.74M |
Short Previous Month | 10.02M |
Short % of Shares Out | 8.52% |
Short % of Float | 15.68% |
Short Ratio (days to cover) | 9.03 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -153.96M |
Pretax Income | -34.94M |
Net Income | -38.68M |
EBITDA | -149.44M |
EBIT | -153.96M |
Earnings Per Share (EPS) | -$0.61 |
Full Income Statement Balance Sheet
The company has $431.53 million in cash and $6.67 million in debt, giving a net cash position of $424.86 million or $3.37 per share.
Cash & Cash Equivalents | 431.53M |
Total Debt | 6.67M |
Net Cash | 424.86M |
Net Cash Per Share | $3.37 |
Equity (Book Value) | 472.37M |
Book Value Per Share | -7.73 |
Working Capital | 429.67M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$122.10 million and capital expenditures -$31.11 million, giving a free cash flow of -$153.21 million.
Operating Cash Flow | -122.10M |
Capital Expenditures | -31.11M |
Free Cash Flow | -153.21M |
FCF Per Share | -$1.22 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |